The Data Extraction and Longitudinal Trend Analysis network study of distributed automated postmarket cardiovascular device safety surveillance

Circulation: Cardiovascular Quality and Outcomes

Volumn 8, Issue 1, 2015, Pages 38-46

  Kumar, Amit ^a,b   Matheny, Michael E ^c   Ho, Kalon K L ^d,e   Yeh, Robert W ^e,f   Piemonte, Thomas C ^a,b   Waldman, Howard ^e,g   Shah, Pinak B ^e,h   Cope, Richard ⁱ   Normand, Sharon Lise T ^e,j   Donnelly, Sharon ^h   Robbins, Susan ^a   Resnic, Frederic S ^a,b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g NORTH SHORE MEDICAL CENTER   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ Boston Advanced Analytics   (United States)

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Safety

Indexed keywords

ADULT; AGED; ALARM MONITOR; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; BLOOD VESSEL INJURY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DATA EXTRACTION AND LONGITUDINAL TREND ANALYSIS SYSTEM; DEVICE SAFETY; DRUG ELUTING CORONARY STENT; EMBOLIC PROTECTION DEVICE; FALSE ANEURYSM; FEMALE; GROIN BLEEDING; HEART INFARCTION; HEMATOMA; HOSPITAL INFORMATION SYSTEM; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPENSITY SCORE; REFERENCE VALUE; RETROPERITONEAL HEMORRHAGE; SENSITIVITY ANALYSIS; STENT COMPLICATION; VASCULAR CLOSURE DEVICE; ADVERSE EFFECTS; CLINICAL TRIAL; DEVICES; DRUG ELUTING STENT; EQUIPMENT DESIGN; LONGITUDINAL STUDY; MASSACHUSETTS; MULTIVARIATE ANALYSIS; PATIENT SAFETY; POSTMARKETING SURVEILLANCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

DRUG-ELUTING STENTS; EMBOLIC PROTECTION DEVICES; EQUIPMENT DESIGN; EQUIPMENT SAFETY; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MASSACHUSETTS; MULTIVARIATE ANALYSIS; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRODUCT SURVEILLANCE, POSTMARKETING; PROPENSITY SCORE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CLOSURE DEVICES;

EID: 84927672804     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.114.001123     Document Type: Article

References (28)

1. Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT. Early failure of a small-diameter high-voltage implantable cardioverterdefibrillator lead. Heart Rhythm. 2007;4:892-896.
2. Steele GD, Fehring TK, Odum SM, Dennos AC, Nadaud MC. Early failure of articular surface replacement total hip arthroplasty. J Arthroplasty. 26:14-18.
3. Maisel WH. Semper fidelis-consumer protection for patients with implanted medical devices. N Engl J Med. 2008;358:985-987.
4. Shah JS, Maisel WH. Recalls and safety alerts affecting automated external defibrillators. JAMA. 2006;296:655-660.
5. Maisel WH. Unanswered questions-drug-eluting stents and the risk of late thrombosis. N Engl J Med. 2007;356:981-984.
6. Rosen CJ. The rosiglitazone story-lessons from an FDA Advisory Committee meeting. N Engl J Med. 2007;357:844-846.
7. Kessler DA. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. JAMA. 1993;269:2765-2768.
8. Mehran R, Leon MB, Feigal DA, Jefferys D, Simons M, Chronos N, Fogarty TJ, Kuntz RE, Baim DS, Kaplan AV. Post-market approval surveillance: a call for a more integrated and comprehensive approach. Circulation. 2004;109:3073-3077.
9. FDA. Manufacturer and User Facility Device Experience Database - (MAUDE). http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/ReportingAdverseEvents/ucm127891.htm.
10. FDA. FDA Adverse Event Reporting System (FAERS). http://www.fda. gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm.
11. FDA. FDA Medical Devices Post-Approval Studies. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/PostApprovaStudies/default.htm.
12. O'Shea JC, Kramer JM, Califf RM, Peterson ED. Part I: Identifying holes in the safety net. Am Heart J. 2004;147:977-984.
13. Vidi VD, Matheny ME, Resnic FS. Post-marketing device safety surveillance. Contemp Clin Trials. 2011;32:307-308.
14. Normand SL, Hatfield L, Drozda J, Resnic FS. Postmarket surveillance for medical devices: America's new strategy. BMJ. 2012;345:e6848.
15. Resnic FS, Normand SL. Postmarketing surveillance of medical devices-filling in the gaps. N Engl J Med. 2012;366:875-877.
16. FDA. Strengthening our national system for medical device postmarket surveillance. 2012. http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDRH/CDRHReports/UCM301924.pdf.
17. FDA. Strengthening our national system for medical device postmarket surveillance: Update and next steps. 2013. http://www.fda.gov/downloads/MedicalDevices/Safety/CDRHPostmarketSurveillance/UCM348845.pdf.
18. Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J. 2007;153:606-611.
19. Hauser RG, Mugglin AS, Friedman PA, Kramer DB, Kallinen L, McGriff D, Hayes DL. Early detection of an underperforming implantable cardiovascular device using an automated safety surveillance tool. Circ Cardiovasc Qual Outcomes. 2012;5:189-196.
20. Resnic FS, Gross T P, Marinac-Dabic D, Loyo-Berrios N, Donnelly S, Normand SL, Matheny ME. Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA. 2010;304:2019-2027.
21. Matheny ME, Morrow DA, Ohno-Machado L, Cannon CP, Sabatine MS, Resnic FS. Validation of an automated safety surveillance system with prospective, randomized trial data. Med Decis Making. 2009;29:247-256.
22. Matheny ME, Ohno-Machado L, Resnic FS. Monitoring device safety in interventional cardiology. J Am Med Inform Assoc. 2006;13:180-187.
23. Vidi VD, Matheny ME, Donnelly S, Resnic FS. An evaluation of a distributed medical device safety surveillance system: the DELTA network study. Contemp Clin Trials. 2011;32:309-317.
24. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, Harrington RA, Krumholz HM, Simoons ML, Van De Werf FJ, Weintraub WS, Mitchell KR, Morrisson SL, Brindis RG, Anderson HV, Cannom DS, Chitwood WR, Cigarroa JE, Collins-Nakai RL, Ellis SG, Gibbons RJ, Grover FL, Heidenreich PA, Khandheria BK, Knoebel SB, Krumholz HL, Malenka DJ, Mark DB, Mckay CR, Passamani ER, Radford MJ, Riner RN, Schwartz JB, Shaw RE, Shemin RJ, Van Fossen DB, Verrier ED, Watkins MW, Phoubandith DR, Furnelli T. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38:2114-2130.
25. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150-161.
26. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, Moses JW, Stone GW, Leon MB, Pocock SJ, Dangas G. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200-1209.
27. Resnic FS, Wang TY, Arora N, Vidi V, Dai D, Ou FS, Matheny ME. Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry. JACC. Cardiovasc Interv. 2012;5:82-89.
28. Griese DP, Reents W, Diegeler A, Kerber S, Babin-Ebell J. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2013;82:E734-E741.